Voluntary ex ante transparency notice
Directive 2014/24/EU
Section I: Contracting
entity
I.1) Name and addresses
NHS Wales Shared Services Partnership
8th Floor, Brecknock House, UHW, Heath Park Way
Cardiff
CF14 4XW
UK
Telephone: +44 2920743261
E-mail: Jacob.stokes@wales.nhs.uk
NUTS: UK
Internet address(es)
Main address: http://www.procurement.wales.nhs.uk
Address of the buyer profile: https://www.sell2wales.gov.wales/search/Search_AuthProfile.aspx?ID=AA0221
I.4) Type of the contracting authority
Body governed by public law
I.5) Main activity
Health
Section II: Object
II.1) Scope of the procurement
II.1.1) Title
Purchase of Illumina NovaSeq Sequencing System
Reference number: 18/2851
II.1.2) Main CPV code
38000000
II.1.3) Type of contract
Supplies
II.1.4) Short description
Cardiff & Vale uLHB intends to purchase an Illumina NovaSeq 6000 sequencing system to improve and increase the provision of genetic tests that is offered by the All Wales Genetics Service. This equipment will be compatible with existing Illumina platforms. The purchase will include associated maintenance service plan.
II.1.6) Information about lots
This contract is divided into lots:
No
II.1.7) Total value of the procurement
Value excluding VAT:
956 822.90
GBP
II.2) Description
II.2.2) Additional CPV code(s)
38000000
II.2.3) Place of performance
NUTS code:
UKL22
Main site or place of performance:
All Wales Genetics Service
II.2.4) Description of the procurement
The NovaSeq 6000 System is a high-throughput genetic sequencing platform. It offers scalable throughput and flexibility for virtually any sequencing method, genome, and scale. The NovaSeq is compatible with the All Wales Genetics Service platforms, and provides consistency and continuity for greater reliability.
The NovaSeq will improve and increase the provision of genetic tests that we offer at the All Wales Genetics Service. It will also allow the service to offer urgent genetic services because the instrument generates sequencing results much faster. The NovaSeq is very adaptable, and allows several ‘types’ of genetic tests to be sequenced simultaneously. And the instrument is user friendly, it is more efficient than the current instruments. It will streamline the workflow for sequencing within the laboratory, reducing test costs by reducing the cost of sequencing consumables when compared with current sequencing methods we have in the laboratory.
There will be a demand for use of the instrument from other stakeholders, especially from research because it supports a broad range of applications.
The NovaSeq will future-proof the provision of genetic services for Welsh patients, and will allow the service to deliver a comparable genetic service to that of other devolved countries.
II.2.11) Information about options
Options:
No
II.2.13) Information about European Union funds
The procurement is related to a project and/or programme financed by European Union funds:
No
Section IV: Procedure
IV.1) Description
IV.1.1) Type of procedure
Award of a contract without prior publication of a call for competition
Justification for selected award procedure:
The procurement falls outside the scope of application of the Directive
Explanation:
There is clinical risk associated with varying equipment from multiple suppliers and platforms. To mitigate the clinical risk, the requirement is only for the purchase of a NovaSeq 6000 sequencing system. Illumina is regarded as the only supplier of this equipment, and therefore no other supplier is considered.
IV.1.8) Information about Government Procurement Agreement (GPA)
The procurement is covered by the Government Procurement Agreement:
Yes
Section V: Award of contract/concession
Contract No: 18/2851
V.2 Award of contract/concession
V.2.1) Date of conclusion of the contract/concession
14/02/2019
V.2.2) Information about tenders
The contract has been awarded to a group of economic operators:
No
V.2.3) Name and address of the contractor
Illumina Cambridge Ltd
Watson Building, 11 Granta Park
Cambridge
CB21 6GP
UK
Telephone: +44 1223885900
NUTS: UK
The contractor is an SME:
No
V.2.4) Information on value of the concession and main financing terms (excluding VAT)
Total value of the concession/lot:
956 822.90
GBP
V.2.5) Information about subcontracting
Section VI: Complementary information
VI.3) Additional information
NOTE: To register your interest in this notice and obtain any additional information please visit the Sell2Wales Web Site at https://www.sell2wales.gov.wales/Search/Search_Switch.aspx?ID=89813.
(WA Ref:89813)
VI.4) Procedures for review
VI.4.1) Review body
NHS Wales Shared Services Partnership
8th Floor Brecknock House, UHW, Heath Park Way
Cardiff
CF14 4XW
UK
Telephone: +44 2920743261
E-mail: Jacob.Stokes@wales.nhs.uk
Internet address(es)
URL: http://www.procurement.wales.nhs.uk
VI.4.2) Body responsible for mediation procedures
NHS Wales Shared Services Partnership
8th Floor Brecknock House, UHW, Heath Park Way
Cardiff
CF144XW
UK
Telephone: +44 2920743261
E-mail: Jacob.Stokes@wales.nhs.uk
VI.4.3) Review procedure
Precise information on deadline(s) for review procedures:
23:59 23rd February 2019
VI.4.4) Service from which information about the review procedure may be obtained
NHS Wales Shared Services Partnership
8th Floor Brecknock House, UHW, Heath Park Way
Cardiff
CF14 4XW
UK
Telephone: +44 2920743261
E-mail: Jacob.Stokes@wales.nhs.uk
VI.5) Date of dispatch of this notice
14/02/2019